Health Canada
- Status: approved
🇨🇦 Roflumilast alternated days in Canada
Roflumilast alternated days (Roflumilast alternated days) regulatory status in Canada.
Marketing authorisation
Roflumilast alternated days in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Roflumilast alternated days approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Roflumilast alternated days in Canada?
Fundación Pública Andaluza Progreso y Salud is the originator. The local marketing authorisation holder may differ — check the official source linked above.